Terri Wilder, M.S.W.
Terri L. Wilder, M.S.W., has been part of the HIV community since 1989, and has been a reporter and writer for TheBody/TheBodyPro since 2007. She served on the New York Governor's Task Force to End AIDS, was recognized by POZ magazine for her work in HIV, and is highlighted in the book Fag Hags, Divas and Moms: The Legacy of Straight Women in the AIDS Community by Victoria Noe. She loves this community and will keep fighting until the epidemic is over.
Latest by Terri Wilder, M.S.W.
Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work
Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.
The HIV services organization Housing Works implemented a hepatitis C treatment program in New York City, with very high completion rates.
One New York-based provider who works specifically with trans and gender non-conforming patients outlines what needs to change in the health care world to get Black trans women the care they deserve.
Even after a series of reforms in 2015, advocates say U.S. policy still discriminates and furthers HIV stigma. Anthony Santella, Dr.P.H., M.P.H., has a better idea.
For people taking medications for HIV prevention, HIV treatment, STIs, or transgender health care, this couple -- in life and in business -- seeks to revolutionize the pharmacy experience at TIN Rx in San Francisco.
Asa Radix, M.D., M.P.H., discusses providing quality care to transgender people. It can be done.
Plans to expand the program to the entire state are underway.
Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results
Newly presented data from IAS 2019 spark discussion about study populations, study endpoints, and potential weight gain.